国际肿瘤学杂志››2012,Vol. 39››Issue (2): 123-126.

• 综述 •上一篇下一篇

替吉奥在晚期头颈鳞状细胞癌治疗中的应用

张吉, 马静, 李晓江

  1. 650118昆明,云南省肿瘤医院 云南省头颈肿瘤研究中心
  • 出版日期:2012-02-08发布日期:2012-01-18
  • 通讯作者:李晓江,E-mail:xiaojiangle@yahoo.com.cn E-mail:xiaojiangle@yahoo.com.cn

Therapeutic application of S-1 in advanced squamous cell carcinoma of the head and neck

ZHANG Ji, MA Jing, LI Xiao-Jiang

  1. Department of Head and Neck Surgery ,Third Affiliated Hospital of Kunming Medical University,Head and Neck Tumor Research Center of Yunnan Province,Kunming 650118,China
  • Online:2012-02-08Published:2012-01-18
  • Contact:Corresponding author: Li Xiao-jiang, E-mail: xiaojiangle@yahoo.com.cn E-mail:xiaojiangle@yahoo.com.cn

摘要:在头颈鳞状细胞癌(HNSCC)的临床治疗中,替吉奥(S-1)可联合其他化疗药物或者联合放疗组成多种方案对其进行治疗,产生的不良反应能很好耐受。替吉奥联合放疗的方案也正逐渐应用于控制局部复发及远处转移,有关的治疗研究也显示出了很好的应用价值。

关键词:font-family: 宋体,mso-ansi-language: EN-US,mso-fareast-language: ZH-CN,mso-bidi-language: AR-SA,mso-bidi-font-family: 'Times New Roman',mso-font-kerning: 1.0pt">替吉奥,头颈部肿瘤,药物疗法

Abstract:In the therapeutic application of head and neck squamous cell carcinoma (HNSCC), S-1 is used to combine with other chemotherapeutics oreven with radiotherapy to constitute chemoradiotherapyregimens. Adverse effects are well tolerated. Regimens containing S-1 are wildly used to control distant metastasis as well as local recurrence. The studies of treatment also show good application value.